漢方の将来ビジョン 2040 ～ 国民の健康と医療を担う ～

2018 年 7 月

日本漢方生薬製剤協会

2001 21

5

2017 3 5

2018 5 2040

2040

2040

2018 7

2000

1 9 1

GQP GVP

1969

1940

ABS Access and Benefit-Sharing

Convention on Biological Diversity ABS

EBM Evidence-Based Medicine

GACP Good Agricultural and Collection Practices 2014

GACP

GMP Good Manufacturing Practices

GMP GMP GMP

GMP

GQP Good Quality Practices

GVP Good

Vigilance Practices

ISO/TC249 International Organization for Standardization “Traditional Chinese

Medicine” 249 Technical Committee

2009

JLOM (Japan Liaison of Oriental Medicine

2005 5

WHO

10

ISO/TC249

PIC/S Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme

2014

SDGs Sustainable Development Goals

21

2040

2040

- 1 -

21

2001 2121

1 EBM

1

EBM EBM

90 2017 10

22003 2007

5 46

2

1

2 2010

2011 1) 200880

5 30

2011 3 2006 1008 2014 2.4 2)

－ 1 －

- 2 -

3 1 2012

2013 20158

2016 2017

2014

GACP 3

1 GMP 2007 GMP GMP

GMP 2012 PIC/SGMP

2 2005 2006

3-7)

8,9)

3 2006 15

6 17 201935

14 2001 4

1

PMDA

－ 2 －

- 3 -

2

10)

Q&A VOL1 VOL2

5 210

20033 210

852008 2010 2011

2012 84 29411)

6

1 1999

12)

2 2000

3 2001

2007 2018

－ 3 －

- 4 -

2040

1983

1998 21

2001 21

6 7

5 20072012 2017

ISO/TC249 ABS

2016

32017 3

21 20

2040

－ 4 －

- 5 -

2040

1

1

EBM

2

3

PMDA

－ 5 －

- 6 -

2

1

3 80

2

3

1995

－ 6 －

- 7 -

3

1

GMP

2

GMP

GACP

3 ISO/TC249 2009 ISO ISO/TC249

JLOM

GMP

IS

ISO/TC249 ISO

－ 7 －

- 8 -

4

2018

4

1

PMDA

5

1

QOL

－ 8 －

- 9 -

21975 210 2008

294

3

4

－ 9 －

- 10 -

6

1

2GQP GVP

2017 6

1

2016 SDGs

－ 10 －

- 11 -

2 ABS

3

8

1

2

3

－ 11 －

【資料編】

- 12 -

1

1

1

2 1

2

－ 13 －

- 13 -

31

2008 201113) 2011 89%

2008 5.5

6.36.8 4.6

2 2011

3

－ 14 －

- 14 -

22001

2004 80

20112017

3

20032013

2006

2008

GMP

4 1

1973 1975“Convention on International Trade in Endangered Species of Wild Fauna and Flora ”

CITES

－ 15 －

- 15 -

2 ABS1993

ABS 201010 ABS

ABS

32011

OTC2013 2030

25 CO2

4 ISO/TC249 2009 ISO “Traditional Chinese Medicine”

ISO/TC249 ISO/TC249 JLOMJLOM

TC249ISO/TC249 WG1 5

WG WG1( ) WG2 WG3 4WG5

2012 WG2 GMP

2017 2018 IS

－ 16 －

- 16 -

5 ICD-11 WHO 30 2018 6 11ICD-11 ICD-11 26 -

－ 17 －

- 17 -

11

17 2242015 72 3

GMP

1 4

2

－ 18 －

- 18 -

3

GMP GMP

11985

2 GMP

1980 GMP

GMP 1988

GMP 1993GMP

GMPGMP

GMP

2007

GMP GMPGMP

－ 19 －

- 19 -

2012 3 PIC/S 2014 7

PIC/S GMPGMP

PIC/S GMP2012

PIC/S GMP

3

1990

DDT BHC1997 4

13

1996 6

2005 2006

4

－ 20 －

- 20 -

1996

WHO

2001 4 14

10

35014)

2016 17

15)

5 2011 3

9

17 53

10

1712

－ 21 －

- 21 -

17

2

12010

2011

200880

2008 21,000 2016 27,00080

3 9 250 2702016 264 26,784

8934 4

3

－ 22 －

- 22 -

4 2016

2011

201430 1 2006

100 8 2.45

1

2008

－ 23 －

- 23 -

5

72004 2014-2015 4.6 2016 3.6 6

6. 7

－ 24 －

- 24 -

2007

2017

2006 2016 49322 2006

4 2016 27 2006 2016

2.3 1.2

7

21

1995 2005

2008

AQSIQAQSIQ

－ 25 －

- 25 -

2014

2015

7

2

2014 2003 1020 8

8 2003 2014

－ 26 －

- 26 -

20152015 2020 9

1060

9 2015 2020

3

30100

－ 27 －

- 27 -

1

20123

2013

8 7

2013 20158

500

1002013 2017

36 41 2016

8

2016 70 2017602 30

－ 28 －

- 28 -

2017 200

2018 2016 17

1

7

2

2018AMED

2016

AMED

3 2017 2020

2017

28

10

－ 29 －

- 29 -

90

2017 2020

4 GACP

2014 GACP

GACP

GACP 3

1

16) 20156 8,204 1,671

2.4 520 1,54792.6 510 35 2.1 590

88 5.32015 1,671

1,321 79 350 2110

1976510

1990510 520 5903 3 3

－ 30 －

- 30 -

10

21

1957 35

2101972 1974 4 1975

2002

2003

3 2004 4210

－ 31 －

- 31 -

210 85

2008 2132010 23 2011 27

2012 31 2942017 16

28

2

1961 () 1942

1957

1967 4

1976 38

1978 1981 1984147

2

－ 32 －

- 32 -

2

1

2 7 5200120 5200121 5200146

5200147

147

3 269 148

148

2016 148148

3

590 19672 1974 1978 1984 1992 1994

1996 2000 12 22007 10

1967 6 29 1967 7 1 4 4

1976 9 1 1976 9 1 37 41

1978 4 1 1978 4 1 46 87

1981 8 31 1981 9 1 58 145

1984 6 2 1984 6 2 3 148

1986 10 30

1995 11 22

1986 10 30

1995 11 23

147 148

2018 3 5 2018 4 1 148 148

－ 33 －

- 33 -

3

4 15

5

18

WG 15 6

4 1734

1717

4

1967 6 29 1967 7 1

1974 1 21 1974 2 1 2 4

1978 4 1 1978 4 1 1 5

1984 2 10 1984 3 1 2 7

1992 3 10 1992 4 1 8

1994 3 10 1994 4 1 2 10

1996 3 10 1996 4 1 1 11

2000 3 10 2000 4 1 1 12

2004 3 5 2004 4 1 11

2007 6 29 2007 7 1 10

2008 3 5 2008 4 1 10

2018 3 5 2018 4 1 10

－ 34 －

- 34 -

4No

1

15 2006 4 1

9

2 6

3 3

4 44

5 1

6 35

7 15 2007 10 1

15

8 14

9 15 2009 10 1

8

10 47

11 16

12

16 2011 4 1

37

13 29

14 18

15 5

16 17

17 32

18 11

19 2

20 22

21 7

22 4

23 16 2012 10 1

12

24 24

25

16 2014 2 28

38

26 34

27 43

28 42

29

17 2016 4 1

20

30 36

31 25

32 13

33

34 17 2017 12 1 10

35 17 2019 5 1 40

1

2 2015 2017

6

－ 35 －

- 35 -

32002

2007

2012 2014

2015

2017 AMED

15

8

32018

41

2017

2011 2015 5

2 18

－ 36 －

- 36 -

QOL

2

1960 1963

1965

43200

2006 2006 112008 37 2008

3 2018 62

73 61 11 1

－ 37 －

- 37 -

3

2017 12

30

19 2018 42018 3

41

11991 8

19951996

17-19) 2014 87

－ 38 －

- 38 -

2

56 2007 3 902017 10 2003 2007

5 46

EBMrandomized controlled trial: RCT

structured abstract: SAEKAT EBM

EKAT Appendix 2014EKAT Appendix 2015

2016 KCPG

3 2009 Surgery

20

Michael G. Sarr Mayo Clinic43

201345

Kampo medicine herbal medicine

4

2003EBM

AURActual Use Research 2003 2007

－ 39 －

- 39 -

105 29102 28 97 23

77 12

AUR

21-26)

2009 AUR

35188

27,28)

21

1996

0.1

PMDA

1995 148

2001

2 1993

－ 40 －

- 40 -

14 2001 ISO/TC249 JLOM

2017 IS

3

Q&A VOL1 VOL2

2003 3

29)

2008

2015 12

2017 10

－ 41 －

- 41 -

2017 11 8

51

1999 1 410

11

2

2000

32001

2007

2018

6 1

20112012

－ 42 －

- 42 -

2IFPMA

31

2005

GQP GVP

2

－ 43 －

- 43 -

11

89

2

－ 44 －

- 44 -

PMDA

AMED

2017 3

32016

2016 8 3QOL

2016 10 26

2016 11 21

－ 45 －

- 45 -

2017 2 9

2017 2017 2017 12 12 2017

Cost-saving

22016 8 3

1

Cost-saving

－ 46 －

- 46 -

2

3

PMDA AMED

4

－ 47 －

- 47 -

5 Made in JAPAN

6

31

1 61 2

12

－ 48 －

- 48 -

21

2 1

3 2

4

－ 49 －

- 49 -

5

6

7ISO/TC249

JLOM

8 1

9 2

－ 50 －

- 50 -

1 http://www.nikkankyo.org/serv/serv3.htm 2 http://www.nikkankyo.org/serv/serv2.htm 3 http://www.nikkankyo.org/serv/serv4.htm 4 ( 1 )

39, 63-75 (2008).

5 ( 2 ) 39, 76-82 (2008).

6 ( 3 ) 66, 81-90 (2012).

7) ( 4 ) 70, 72-78 (2016).

8 ( 1 ) 65, 10-17 (2011).

9 ( 2 ) 68, 78-87 (2014).

10 http://www.nikkankyo.org/seihin/seihin2.htm 11

2013 12 http://www.nikkankyo.org/kampo/kampo3.htm 13 http://www.nikkankyo.org/serv/pdf/jittaichousa2011.pdf 14 69, 10-17 (2015). 15 2016, pp. 124-133, p. 2422. 16 http://www.nikkankyo.org/serv/serv5.htm 17

20, 751-759 (1990). 18 ( ) (TJ-84)

18, 299-312 (1994). 19

88, 389-405 (1995). 20 Kono, T. et al, Exodus of Kampo, traditional Japanese medicine, from the

complementary and alternative medicine : is it time yet? Surgery, 1146, 837--840(2009) 21 AUR(Actual Use Research)

22 2005, p. 212. 22 AUR(Actual Use Research)

52 2005, p. 111. 23 AUR(Actual Use Research)

126 2006, Vol.4, p. 205. 24 AUR(Actual Use Research) AUR

24, 104-114 (2007). 25 AUR(Actual Use Research)

55 2008, p. 304. 26 Actual Use Research (AUR), a New Method for Evaluating the Effectiveness

of OTC Kampo Formulations 62, 1-7 (2008). 27

1 28 2011, p. 68. 28

2 58 2011, p. 104. 29 Jpn. J. Drug Inform., 111, 210-216

(2010).

－ 51 －

2040

2018 7 20

1983 7 21

2018 7 65

TK